Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

14,382 studies for “lung cancer”

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung CancersTerminated
NCT05616624Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Non Small Cell Lung Cancer · Non-small Cell Lung Cancer · Small-cell Lung Cancer · Small Cell Lung Carcinoma
United States
COVICI-SURV: COVID-19 Vaccination Around ICI Start and SurvivalActive Not Recruiting
NCT07729241N/AUpdated Jul 27, 2026
Sponsor: Groupe Hospitalier Pitie-Salpetriere
Cancer · Immune Checkpoint Inhibitors · COVID-19 Vaccination · Survival
France
Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung CancerActive Not Recruiting
NCT04612751Phase 1Updated Jul 27, 2026
Sponsor: AstraZeneca
Advanced or Metastatic NSCLC
United States, Belgium, Italy, Japan, Poland +3 more
Multicenter Prospective Validation of AI Models for Malignancy Risk Prediction in Pulmonary NodulesNot Yet Recruiting
NCT07727122N/AUpdated Jul 27, 2026
Sponsor: Guangdong Provincial People's Hospital
Pulmonary Nodules
China
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory DiseaseNot Yet Recruiting
NCT07509034Phase 1Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Extensive-Stage Small Cell Lung Cancer · Extrapulmonary Neuroendocrine Carcinoma · Recurrent or Refractory · Solid Tumors
United States
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsRecruiting
NCT06465069Phase 1Updated Jul 27, 2026
Sponsor: Eli Lilly and Company
Metastatic Solid Tumor · Recurrent Solid Tumor · Advanced Solid Tumor · Urinary Bladder Neoplasm
United States, Australia, China, France, Japan +3 more
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Recruiting
NCT06623422Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Belgium, Brazil +26 more
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung CancerRecruiting
NCT07155174Phase 2Updated Jul 27, 2026
Sponsor: AbbVie
Small Cell Lung Cancer
United States, Belgium, China, Germany, Israel +7 more
JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLCActive Not Recruiting
NCT06944470Phase 2Updated Jul 27, 2026
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
NSCLC
China
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)Recruiting
NCT07513376Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Australia, Canada, Germany, Greece +8 more
Preliminary Evaluation of a Large Language Model-Based Tool for Complex Surgical Decision Support in Lung CancerCompleted
NCT07654036NAUpdated Jul 27, 2026
Sponsor: Peking University People's Hospital
Large Language Models · Lung Cancer (NSCLC)
China
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)Active Not Recruiting
NCT05250037N/AUpdated Jul 27, 2026
Sponsor: Fred Hutchinson Cancer Center
Bronchiolitis Obliterans Syndrome · Hematopoietic and Lymphoid Cell Neoplasm
United States
A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07)Recruiting
NCT07502300Phase 3Updated Jul 27, 2026
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Extensive-stage Small-cell Lung Cancer
China
A Study of IDP-001 in Advanced or Metastatic Solid TumorsNot Yet Recruiting
NCT07602842Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: InduPro, Inc.
Advanced Solid Tumor · Metastatic Solid Tumor · Head and Neck Squamous Cell Carcinoma · Cutaneous Squamous Cell Carcinoma
United States
A Single-arm, Exploratory Clinical Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Anlotinib and Etoposide as First-line Therapy for Elderly Patients With Small-cell Lung Cancer or Those Who Are Intolerant to Intensive ChemotherapyNot Yet Recruiting
NCT07728955Phase 3Updated Jul 27, 2026
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Small Cell Lung Cancer ( SCLC )
A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung CancerRecruiting
NCT05242965Phase 2Updated Jul 27, 2026
Sponsor: University of Washington
Lung Non-Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
United States
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid TumorsRecruiting
NCT07660055Phase 1Updated Jul 27, 2026
Sponsor: Novartis Pharmaceuticals
Breast Cancer · Non-small Cell Lung Cancer (NSCLC) · Gastric/Gastroesophageal Junction (GEJ) Cancer · Bladder Cancer
Australia, Canada, Japan
Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer.Active Not Recruiting
NCT06992609Phase 3Updated Jul 27, 2026
Sponsor: AstraZeneca
Small Cell Lung Carcinoma
Spain
Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)Recruiting
NCT06694454Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Non-small Cell Lung Cancer (NSCLC) · Carcinoma, Non-Small Cell Lung · Non-Small Cell Lung Carcinoma · Non Small Cell Lung Cancer
United States
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])Recruiting
NCT04267848Phase 3Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma · Lung Non-Small Cell Squamous Carcinoma · Lung Non-Squamous Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8
United States, Guam
Clinical Genetics Branch Eligibility Screening SurveyNot Yet Recruiting
NCT07005297N/AUpdated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Melanoma · Li-Fraumeni Syndrome · Pulmonary Blastoma · Chordoma
United States
A Stepped Intervention for Coping With Dyspnea in Patients With Lung Cancer-Phase A (Open Pilot)Not Yet Recruiting
NCT07728773NAUpdated Jul 27, 2026
Sponsor: Massachusetts General Hospital
Dyspnea · Lung Cancer (Diagnosis)
United States
Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant MesotheliomaActive Not Recruiting
NCT01843374Phase 2Updated Jul 27, 2026
Sponsor: MedImmune LLC
Unresectable Pleural or Peritoneal Malignant Mesothelioma
United States, Australia, Belgium, Canada, Denmark +14 more
Intratumoral N17350 in Advanced Solid TumorsRecruiting
NCT07339176Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: Onchilles Pharma Inc
Neoplasms, Solid Tumor · Breast Neoplasms, Triple-Negative · Squamous Cell Carcinoma of Skin · Melanoma
United States, Australia
Safety and Tolerability of IPH4502 in Patients With Advanced Solid TumorsActive Not Recruiting
NCT06781983Phase 1Updated Jul 27, 2026
Sponsor: Innate Pharma
Advanced or Metastatic Solid Tumors
United States, France

14,382 studies found